Now Accepting Submissions for Novel hMSC Applications in Europe and North America

Application Deadline: May 31st, 2022

Award Total: Up to $10,000 in applicable RoosterBio® products to be used over a 12 month period

Human mesenchymal stromal cells (hMSCs) are a critical raw material for a growing number of emerging regenerative medicine (RM) applications including cell and gene therapies, engineered tissues, combination products/medical devices, and exosome / extracellular vesicle (EV) based therapies. ...  Read more

Application deadline EXTENDED to Monday, May 16. ...  Read more

TEDCO’s Seed Funds are invested in companies that show promise of becoming venture fundable companies or are companies that, through a seed investment, will be sustainable through customer revenue, follow-on funding, or other forms of corporate venture. ...  Read more

Expanded Collaboration Agreement to Make Less Invasive Blood Sample Collection More Convenient and Patient Centered ...  Read more

SYNAPS Dx announces it will present “Physicians’ Assessment of the Clinical Utility of a Novel Test to Diagnose Alzheimer’s Disease (AD),” at the ISPOR Annual Conference. The implicit preference study indicates that 90% of physicians would routinely use the results of DISCERN™, a diagnostic test that assesses the factors directly related to the formation of synaptic connections in the brain impacting loss of memory and cognition in people living with AD as well as regulators of amyloid plaque and tau formation, hallmarks of AD at autopsy. ...  Read more

Channel Program, a rapidly growing social and media platform that is unifying the IT Channel industry, announced it is hosting what is anticipated to be the largest virtual event of the year on June 8, 2022, at 11:30 AM EDT. ...  Read more

DMV Solutions, LLC wins GSA’s 8(a) STARS III, a multi-award Indefinite Delivery Indefinite Quantity (IDIQ) contract #47QTCB22D0060 to provide information technology (IT) services and solutions for the 8(a) Streamlined Technology Acquisition Resource for Services (STARS) III Government-wide Acquisition Contract (GWAC). This fourth-generation contract offers IT services ranging from simple to complex and services-based solutions such as IT help-desk support, information assurance, cybersecurity, artificial intelligence (AI), robotic process automation (RPA), with two focused scope sub-areas: emerging technologies and outside continental United States (OCONUS) support. STARS III partners with the Small Business Administration (SBA) to support the development of small firms and provide federal agencies with methods to deliver mission-critical IT services while working with small businesses. ...  Read more

Maryland Women’s Business Center (MWBC) works with entrepreneurs across Maryland’s capital region by way of three locations. Through our resources, we encourage women to start, sustain, and grow their businesses. Through workshops, individual counseling, facilitated peer group support, special resources, and access to capital, MWBC annually helps more than 1,500 women gain the skills, connections, and confidence necessary to navigate entrepreneurship. ...  Read more

MD MEP is currently accepting applications for the 2022 Manufacturing Internship Program!  ...  Read more

Arlington, Va. – Two Six Technologies, an Arlington-based provider of technology to governments, announced that it has acquired McLean-based Thresher Ventures, a developer of software that detects and analyzes media manipulation by foreign governments. Financial terms of the deal were not disclosed. Thresher’s main product – called M3 (Media Manipulation Monitor) – uses AI, natural language processing and data science to help clients understand manipulation of news and information by foreign governments. “We are thrilled to join the Two Six team and leverage our combined platform to help our clients more quickly and effectively confront the growing threats of misinformation and media manipulation around the world,” said Becky Fair, the CEO and co-founder of Thresher. ...  Read more